Chief Medical Officer.
Dr. Wilding is an expert on genitourinary cancers, particularly prostate cancer and new prostate cancer drug development. He has served as Vice President and Deputy Chief Academic Officer, Clinical and Interdisciplinary Research; Professor, Department of
Genitourinary Medical Oncology at The University of Texas MD Anderson Cancer Center and as Director of Cancer Center and Head of Hematology-Oncology Division at the University of Wisconsin Carbone Comprehensive Cancer Center.
senexbio.com 